Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Humira

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.

AbbVie scores FDA approval for arthritis treatment upadacitinib

AbbVie scores FDA approval for arthritis treatment upadacitinib

Humira has been hit hard by the recent launch of biosimilars, with the drug experiencing rapid losses in Europe. ... If approved in Europe, AbbVie could begin to reclaim Humira’s lost ground in RA.

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

Leo Pharma to market AstraZeneca’s brodalumab outside Europe Abbvie’s Humira (adalimumab) and J&J’s Stelara (ustekinumab) remain the leaders in the market due to the strength of their ability to quickly clear up to 75% of lesions

Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial

Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial AbbVie’s Humira (adalimumab) and J&J’s Stelara (ustekinumab) became, and remain, big selling drugs partly on the strength of their ability to quickly clear up to 75% of lesions

White House unveils plans to reimport medicines from Canada

White House unveils plans to reimport medicines from Canada These limitations would severely restrict the impact of the plans, as these exemptions would include many of the most high cost drugs, such as rheumatoid arthritis drug Humira and cancer treatment

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Takeda makes Crohn’s disease case for subcutaneous Entyvio It is emerging as the dominant antibody therapy for ulcerative colitis after outperforming AbbVie’s TNF blocker Humira (adalimumab) in a head-to-head trial. ... to compete strongly against well-established ulcerative colitis drugs such as Humira and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics